During the past decade, Klinika Onkologii CMuJ conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinika Onkologii CMuJ" are "Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Klinika Onkologii CMuJ" in a lesser frequency.

Most popular intervention types in "Klinika Onkologii CMuJ" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab and Capecitabine" (1 trials), "Bevacizumab and Paclitaxel" (1 trials), "Docetaxel" (1 trials) and "Gemcitabine, Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinika Onkologii CMuJ" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinika Onkologii CMuJ". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Klinika Onkologii CMuJ, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinika Onkologii CMuJ, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".